Guardant Health, Inc.
GH
$48.30
$0.891.88%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.02% | -4.99% | 10.75% | 38.52% | -117.23% |
| Total Depreciation and Amortization | -1.36% | -0.24% | -0.83% | -1.44% | -1.53% |
| Total Amortization of Deferred Charges | 0.16% | 0.00% | 0.00% | 0.16% | 0.00% |
| Total Other Non-Cash Items | -33.70% | 12.92% | -22.02% | 100.66% | 549.89% |
| Change in Net Operating Assets | 76.78% | 77.28% | -782.57% | -87.74% | 864.77% |
| Cash from Operations | -26.35% | 45.68% | -210.40% | 61.53% | -1.20% |
| Capital Expenditure | -349.51% | 17.29% | 26.78% | -70.08% | -71.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 110.12% | -- | -100.00% | -94.76% | 153.75% |
| Cash from Investing | 103.57% | -5,707.11% | -118.09% | -95.77% | 154.49% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 25,045.00% | -99.79% | 4,395.77% | -99.77% | 134,454.29% |
| Repurchase of Common Stock | -179.16% | 11.30% | -109.84% | 49.95% | -2.73% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 290.32% | 92.92% | -270.43% | 148.04% | -107.94% |
| Cash from Financing | -1.73% | -148.91% | 649.16% | -101.19% | 2,278.99% |
| Foreign Exchange rate Adjustments | -189.21% | 327.00% | 26.45% | -210.49% | 295.82% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 83.10% | -268.94% | -2,022.30% | -100.66% | 263.25% |